Chandigarh,13.06.18-Dr. Navneet Singh MD DM, Additional Professor in the Department of Pulmonary Medicine at PGIMER has received a rare honor in the form of being invited to assume the role of Chair of the IDEA Working Group of the American Society of Clinical Oncology (ASCO). ASCO is the world’s largest professional body with a global network of nearly 45,000 oncology professionals (individuals working in the area of cancer care). ASCO is the leading resource provider for practice of clinical oncology in both academic and community settings as well as for oncology research. Dr. Singh took over as Chair at the recently held 54th Annual Meeting of ASCO in the first week of June at Chicago, USA. He will hold this position for a period of 2 years. Dr. Singh leads the multidisciplinary thoracic oncology group at PGIMER and himself specializes in thoracic medical oncology especially targeted therapies and immunotherapy for advanced/metastatic non-small cell lung cancer (NSCLC). He is an invited member of ASCO’s Thoracic Cancer Guideline Advisory Group and was part of the development of guidelines for molecular testing in NSCLC which have been recently published in the prestigious Journal of Clinical Oncology. He has been instrumental in the organization of 3 editions of the Lung Multidisciplinary Cancer Management Course – joint efforts between ASCO, PGIMER Chandigarh, Tata Memorial Hospital Mumbai and the Indian Society for Study of Lung Cancer – Chandigarh (April 2014), Mumbai (March 2016) and Chandigarh again (March 2018). He also works closely with the International Association for Study of Lung Cancer (IASLC) – another global organization dedicated to lung cancer – being a member of its Staging and Prognostic Factors Committee as well as its Council of Regents. With over 150 publications to his credit, Dr. Singh has been a recipient of several awards and honors for his research in the area of lung cancer including the Kamal Satbir Award of the Indian Council for Medical Research (ICMR) in 2014.